Illumina and Veritas Genetics launched a consortium to integrate whole‑genome sequencing into preventive healthcare pathways and create a consented clinical‑genomics dataset. Illumina will supply sequencing and DRAGEN analytics while Veritas will provide myGenome reporting, clinical interpretation and genetic counseling. The program aims to deliver actionable findings, confirmatory testing, specialist referrals and guideline‑aligned screening to participants, with streamlined consent and results delivery. Preventive genomics refers to using genomic data proactively to identify risk factors and guide early interventions before disease onset.